JRSIS HEALTH CARE CORPORATION
Income Statement
| Line Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $3.5M | $1.7M | $44.4M | $35.7M | $31.5M | $28.4M | $24.1M |
| Cost of Revenue | — | $3.0M | $1.7M | — | — | — | — | $7.1M |
| Gross Profit | — | $483.1K | $26.2K | — | — | — | — | $17.1M |
| Gross Margin | — | 14.0% | 1.5% | — | — | — | — | 70.8% |
| Operating Expenses | ||||||||
| Research & Development | — | $189.3K | $283.0K | — | — | — | — | — |
| SG&A Expense | — | $336.0K | $283.3K | — | — | — | — | — |
| Operating Income | — | $-188.6K | $-684.8K | $-103.8K | $5.6M | $4.7M | $6.0M | $6.7M |
| Operating Margin | — | -5.4% | -39.8% | -0.2% | 15.7% | 14.8% | 21.1% | 27.6% |
| Interest Expense | — | $56.4K | $64.7K | $1.4M | $1.1M | $1.1M | $1.1M | $1.3M |
| Pretax Income | — | $-85.6K | $-673.3K | $-103.8K | $5.2M | $1.9M | $5.6M | $6.6M |
| Income Tax Expense | — | $9.0K | — | $1.2M | $1.4M | $657.7K | $2.8M | $2.5K |
| Net Income | — | $-80.9K | $-575.8K | $3.2M | $3.8M | $888.1K | $2.0M | $4.6M |
| Net Margin | — | -2.3% | -33.5% | 7.2% | 10.7% | 2.8% | 7.0% | 19.2% |
| EPS (Basic) | — | $0.00 | $-0.01 | $0.06 | $0.05 | $0.02 | $0.04 | $0.11 |
| EPS (Diluted) | — | $0.00 | $-0.01 | $0.06 | $0.05 | $0.02 | $0.04 | $0.11 |
| Shares Outstanding (Basic) | 82.6M | 77.3M | 61.3M | 55.4M | 54.2M | 50.3M | 44.8M | 44.5M |
| Shares Outstanding (Diluted) | 82.6M | 77.3M | 61.3M | 56.0M | 54.8M | 50.4M | 44.8M | 44.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |